Sensus Healthcare (NASDAQ:SRTS) Stock Crosses Below 50 Day Moving Average – What’s Next?

Sensus Healthcare, Inc. (NASDAQ:SRTS) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.63 and traded as low as $4.57. Sensus Healthcare shares last traded at $4.77, with a volume of 130,239 shares trading hands.

Wall Street Analyst Weigh In

SRTS has been the topic of several recent analyst reports. HC Wainwright raised their price target on shares of Sensus Healthcare from $11.00 to $12.00 and gave the stock a “buy” rating in a research note on Monday, February 10th. Lake Street Capital reduced their target price on shares of Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th.

Sensus Healthcare Stock Up 1.7 %

The stock’s 50 day moving average is $5.63 and its two-hundred day moving average is $6.54. The company has a market capitalization of $78.68 million, a PE ratio of 11.93 and a beta of 1.28.

Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. On average, sell-side analysts predict that Sensus Healthcare, Inc. will post 0.32 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC boosted its position in Sensus Healthcare by 175.5% during the fourth quarter. Squarepoint Ops LLC now owns 85,677 shares of the company’s stock valued at $593,000 after purchasing an additional 54,576 shares in the last quarter. Man Group plc lifted its position in shares of Sensus Healthcare by 34.0% during the fourth quarter. Man Group plc now owns 59,338 shares of the company’s stock valued at $411,000 after buying an additional 15,059 shares during the last quarter. OMERS ADMINISTRATION Corp bought a new stake in shares of Sensus Healthcare in the 4th quarter valued at about $381,000. Millennium Management LLC grew its position in shares of Sensus Healthcare by 256.6% in the 4th quarter. Millennium Management LLC now owns 85,329 shares of the company’s stock worth $590,000 after buying an additional 61,403 shares during the last quarter. Finally, BNP Paribas Financial Markets bought a new position in shares of Sensus Healthcare during the 4th quarter worth approximately $47,000. 25.30% of the stock is currently owned by hedge funds and other institutional investors.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.